UPDATE: Cytogen Sets Up $70M Credit Line to Support Research | GenomeWeb

This story has been updated from a previous version.

NEW YORK, Oct 10 - Biopharmaceutical company Cytogen announced Tuesday that it had reached a deal with Acqua Wellington North American Equities Fund for an equity financing facility of up to $70 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.